Managing Director
Eric Bormel is a Managing Director in Healthcare focused on Digital Health and Consumer Healthtech across software, tech-enabled services and connected device companies. He joined the firm in 2013.
Industry executives and professional publications recognize Eric as a leading investment banker in Digital Health. His experience spans verticals such as AI-enabled care management, corporate wellness, virtual care, consumer med tech, health & wellness tech and connected health & fitness tech.
With more than 12 years of experience in public and private mergers, acquisitions, divestitures, private placements, leveraged financings and restructurings, Eric has advised 25+ clients in industry changing transactions with a combined value exceeding $15 billion.
Select recent strategic clients include Willow Innovations, Prime Therapeutics, Tidi Products, Lululemon Studio, Wahoo Fitness, ProSomnus, Nox Health, Panalgo, Truepill, MyFitnessPal and Under Armour. Select recent financial sponsor clients include Apollo Global Management, Bessemer Venture Partners, CCMP Capital, CRG LP, General Atlantic, Healthpoint Capital, Madryn Asset Management, Oak HC/FT, Optum Ventures, Rhone Group, RoundTable Healthcare Partners, Silversmith Capital Partners, Transformation Capital Partners, and TSG Consumer Partners.
Eric graduated with a BBA, with distinction, from the Ross School of Business at the University of Michigan.
Served as financial advisor to Willow Innovations on its acquisition of Elvie
Served as financial advisor to Prime Therapeutics on its strategic alliance with and minority investment in Capital Rx
Served as financial advisor to TIDI Products on its sale to TJC
Served as financial advisor to lululemon on strategic alternatives for lululemon studio
Served as financial advisor to Zavation on its acquisition of CoreLink
Served as financial advisor to Wahoo Fitness on its recapitalization and growth financing
Served as financial advisor to Vestar Capital on its strategic growth investment in Nox Health
Served as financial advisor to ProSomnus on its merger with Lakeshore Acquisition I SPAC
Served as the exclusive financial advisor and placement agent to Prime Therapeutics on its acquisition of Magellan Rx
Served as financial advisor to Truepill on its $142 million capital raise at a $1.6 billion valuation
Served as exclusive financial advisor to Panalgo on its sale to MMIT & Evaluate, a Welsh, Carson, Anderson & Stowe and Hg portfolio company
Served as financial advisor to Under Armour on its sale of the MyFitnessPal Platform to Francisco Partners
Action Defined the Consumer Healthtech Sector in 2025 From growth in scaled M&A and venture funding to the reopening of US IPO markets, 2025 marked a decisive shift for Consumer Healthtech. Read Managing Director Eric Bormel ’s 2025 Market Report and 2026 Outlook for more insights and trends shaping the sector. DOWNLOAD REPORT Report Contents…
Consumer Healthtech 2024 Market Report Scale proved to be the defining characteristic for Consumer Healthtech in 2024 in another year of impressive growth for the sector. Get insights into the key themes of 2024 and what they mean for the year ahead in our Consumer Healthtech Market Report.
Consumer Healthtech 2023 Market Report Our Consumer Healthtech 2023 Market Report is now available. The report includes M&A, financing, and strategic insights into the dynamic Consumer Healthtech industry, trends that will shape 2024, and more from Director Eric Bormel .
Friends and Colleagues, With another year of M&A and financings in the books, we’re pleased to provide you with our 2022 Year-in-Review. This past year saw a relative return to 2020 levels, after an outlier ’21 in terms of both deal volumes and aggregate value, with ~$14B in disclosed financing proceeds and nearly $70B in…
Consumer Healthtech 2022 Year End Market Report Solomon Partners’ industry report on the Consumer Healthtech Market includes an overview of the M&A and financing environment of the dynamic, high growth Consumer Healthtech industry, and thoughts on trends that will shape 2023. Read the full report below.
Consumer Healthtech 2022 Mid-Year Market Report Solomon Partners’ newest industry report on the Consumer Healthtech Market highlights the resiliency of innovative companies and their leaders despite market turbulence. This mid-year report focuses on software or tech-enabled devices accessed, worn or purchased by consumers to improve one’s health. This 2022 Mid-Year Market Report provides the latest…
With a year like no other now in the rearview mirror, we’re pleased to provide you with our review of a year filled with unfathomable sacrifice, courage and resolve, as well as historic transformation across our healthcare industry, where 10-years of advancements were made in 10 short months! As the world watched, our industry embraced…
With the world waiting in anticipation for a vaccine to COVID-19, the role of specialty pharmacies has never been more essential. As the largest provider of specialty pharmacy in the United States, how does CVS Health think about providing the highest level of quality and service at the lowest cost possible to ensure optimum healthcare…
